APO Research
Talk to an analyst

APO RESEARCH · REPORT

Naoliqing Capsules

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Naoliqing Capsules Market Outlook and Growth Opportunities 2026

29 December 2025202 pages

Choose your research edition.

Industry ResearchNaoliqing Capsules Industry Research Report 2026130 pages · $2,950 USDIndustry Growth & TrendsGlobal Naoliqing Capsules Industry Growth and Trends Forecast to 2032112 pages · $3,450 USDMarket StructureGlobal Naoliqing Capsules Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032191 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Naoliqing Capsules Market Outlook and Growth Opportunities 2026202 pages · $4,250 USDMarket Analysis & ForecastGlobal Naoliqing Capsules Market Analysis and Forecast 2026-2032204 pages · $4,950 USD

Market perspective

The global Naoliqing Capsules market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Naoliqing Capsules is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Naoliqing Capsules is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Naoliqing Capsules is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Naoliqing Capsules market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Naoliqing Capsules market include Xiuzhen Pharmaceutical Group Co., Ltd., Xi'an Tianyi Qinkun Pharmaceutical Co., Ltd., Tonghua Xindongri Pharmaceutical Co., Ltd., Shanxi Tiansheng Pharmaceutical Co., Ltd., Shanxi Yellow River Chinese Medicine Co., Ltd., Shanxi Huayuan Pharmaceutical Biotechnology Co., Ltd., Shanxi Huakang Pharmaceutical Co., Ltd., Liaoyuan Yulong Yadong Pharmaceutical Co., Ltd. and Jilin Zixin Pharmaceutical Co., Ltd., among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Naoliqing Capsules market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Naoliqing Capsules and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Naoliqing Capsules sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Naoliqing Capsules market size, projected growth trends, production technologies, key applications, and end-use industries.

Naoliqing Capsules Segment by Company

Xiuzhen Pharmaceutical Group Co., Ltd.

Xi'an Tianyi Qinkun Pharmaceutical Co., Ltd.

Tonghua Xindongri Pharmaceutical Co., Ltd.

Shanxi Tiansheng Pharmaceutical Co., Ltd.

Shanxi Yellow River Chinese Medicine Co., Ltd.

Shanxi Huayuan Pharmaceutical Biotechnology Co., Ltd.

Shanxi Huakang Pharmaceutical Co., Ltd.

Liaoyuan Yulong Yadong Pharmaceutical Co., Ltd.

Jilin Zixin Pharmaceutical Co., Ltd.

Jilin Yinok Pharmaceutical Co., Ltd.

Jilin Tiantai Pharmaceutical Co., Ltd.

Hubei Nordex Pharmaceutical Co., Ltd.

Heilongjiang Dina Pharmaceutical Co., Ltd.

Hebei Wansui Pharmaceutical Co., Ltd.

Guizhou Hanfang Pharmaceutical Co., Ltd.

Beijing Yadong Biopharmaceutical Co., Ltd.

Beijing Boran Pharmaceutical Co., Ltd.

Naoliqing Capsules Segment by Type

Boxed

Bottled

Naoliqing Capsules Segment by Application

Hospital

Clinic

Other

Naoliqing Capsules Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Naoliqing Capsules status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Naoliqing Capsules market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Naoliqing Capsules significant trends, drivers, influence factors in global and regions.

6. To analyze Naoliqing Capsules competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Naoliqing Capsules market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Naoliqing Capsules and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Naoliqing Capsules.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Naoliqing Capsules market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Naoliqing Capsules industry.

Chapter 3: Detailed analysis of Naoliqing Capsules manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Naoliqing Capsules in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Naoliqing Capsules in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Naoliqing Capsules Industry Trends Table 2. Naoliqing Capsules Industry Drivers Table 3. Naoliqing Capsules Industry Opportunities and Challenges Table 4. Naoliqing Capsules Industry Restraints Table 5. Global Naoliqing Capsules Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Naoliqing Capsules Revenue Share by Company (2021-2026) Table 7. Global Naoliqing Capsules Sales Volume by Company (K Units) & (2021-2026) Table 8. Global Naoliqing Capsules Sales Volume Share by Company (2021-2026) Table 9. Global Naoliqing Capsules Average Price (US$/Unit) of Company (2021-2026) Table 10. Global Naoliqing Capsules Company Ranking, (2024-2026) & (USD Million) Table 11. Global Naoliqing Capsules Key Company Manufacturing Base & Headquarters Table 12. Global Naoliqing Capsules Company, Product Type & Application Table 13. Global Naoliqing Capsules Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Naoliqing Capsules by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Boxed Table 18. Significant Companies of Bottled Table 19. Global Naoliqing Capsules Sales Volume by Type 2021 VS 2025 VS 2032 (K Units) Table 20. Global Naoliqing Capsules Sales Volume by Type (2021-2026) & (K Units) Table 21. Global Naoliqing Capsules Sales Volume by Type (2027-2032) & (K Units) Table 22. Global Naoliqing Capsules Sales Volume Share by Type (2021-2026) Table 23. Global Naoliqing Capsules Sales Volume Share by Type (2027-2032) Table 24. Global Naoliqing Capsules Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Naoliqing Capsules Sales Value by Type (2021-2026) & (US$ Million) Table 26. Global Naoliqing Capsules Sales Value by Type (2027-2032) & (US$ Million) Table 27. Global Naoliqing Capsules Sales Value Share by Type (2021-2026) Table 28. Global Naoliqing Capsules Sales Value Share by Type (2027-2032) Table 29. Significant Companies of Hospital Table 30. Significant Companies of Clinic Table 31. Significant Companies of Other Table 32. Global Naoliqing Capsules Sales Volume by Application 2021 VS 2025 VS 2032 (K Units) Table 33. Global Naoliqing Capsules Sales Volume by Application (2021-2026) & (K Units) Table 34. Global Naoliqing Capsules Sales Volume by Application (2027-2032) & (K Units) Table 35. Global Naoliqing Capsules Sales Volume Share by Application (2021-2026) Table 36. Global Naoliqing Capsules Sales Volume Share by Application (2027-2032) Table 37. Global Naoliqing Capsules Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 38. Global Naoliqing Capsules Sales Value by Application (2021-2026) & (US$ Million) Table 39. Global Naoliqing Capsules Sales Value by Application (2027-2032) & (US$ Million) Table 40. Global Naoliqing Capsules Sales Value Share by Application (2021-2026) Table 41. Global Naoliqing Capsules Sales Value Share by Application (2027-2032) Table 42. Global Naoliqing Capsules Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 43. Global Naoliqing Capsules Sales by Region (2021-2026) & (K Units) Table 44. Global Naoliqing Capsules Sales Market Share by Region (2021-2026) Table 45. Global Naoliqing Capsules Sales by Region (2027-2032) & (K Units) Table 46. Global Naoliqing Capsules Sales Market Share by Region (2027-2032) Table 47. Global Naoliqing Capsules Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 48. Global Naoliqing Capsules Sales Value by Region (2021-2026) & (US$ Million) Table 49. Global Naoliqing Capsules Sales Value Share by Region (2021-2026) Table 50. Global Naoliqing Capsules Sales Value by Region (2027-2032) & (US$ Million) Table 51. Global Naoliqing Capsules Sales Value Share by Region (2027-2032) Table 52. Global Naoliqing Capsules Market Average Price (US$/Unit) by Region (2021-2026) Table 53. Global Naoliqing Capsules Market Average Price (US$/Unit) by Region (2027-2032) Table 54. Global Naoliqing Capsules Sales by Country: 2021 VS 2025 VS 2032 (K Units) Table 55. Global Naoliqing Capsules Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 56. Global Naoliqing Capsules Sales by Country (2021-2026) & (K Units) Table 57. Global Naoliqing Capsules Sales Market Share by Country (2021-2026) Table 58. Global Naoliqing Capsules Sales by Country (2027-2032) & (K Units) Table 59. Global Naoliqing Capsules Sales Market Share by Country (2027-2032) Table 60. Global Naoliqing Capsules Sales Value by Country (2021-2026) & (US$ Million) Table 61. Global Naoliqing Capsules Sales Value Market Share by Country (2021-2026) Table 62. Global Naoliqing Capsules Sales Value by Country (2027-2032) & (US$ Million) Table 63. Global Naoliqing Capsules Sales Value Market Share by Country (2027-2032) Table 64. Xiuzhen Pharmaceutical Group Co., Ltd. Company Information Table 65. Xiuzhen Pharmaceutical Group Co., Ltd. Business Overview Table 66. Xiuzhen Pharmaceutical Group Co., Ltd. Naoliqing Capsules Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 67. Xiuzhen Pharmaceutical Group Co., Ltd. Naoliqing Capsules Product Portfolio Table 68. Xiuzhen Pharmaceutical Group Co., Ltd. Recent Development Table 69. Xi'an Tianyi Qinkun Pharmaceutical Co., Ltd. Company Information Table 70. Xi'an Tianyi Qinkun Pharmaceutical Co., Ltd. Business Overview Table 71. Xi'an Tianyi Qinkun Pharmaceutical Co., Ltd. Naoliqing Capsules Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 72. Xi'an Tianyi Qinkun Pharmaceutical Co., Ltd. Naoliqing Capsules Product Portfolio Table 73. Xi'an Tianyi Qinkun Pharmaceutical Co., Ltd. Recent Development Table 74. Tonghua Xindongri Pharmaceutical Co., Ltd. Company Information Table 75. Tonghua Xindongri Pharmaceutical Co., Ltd. Business Overview Table 76. Tonghua Xindongri Pharmaceutical Co., Ltd. Naoliqing Capsules Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 77. Tonghua Xindongri Pharmaceutical Co., Ltd. Naoliqing Capsules Product Portfolio Table 78. Tonghua Xindongri Pharmaceutical Co., Ltd. Recent Development Table 79. Shanxi Tiansheng Pharmaceutical Co., Ltd. Company Information Table 80. Shanxi Tiansheng Pharmaceutical Co., Ltd. Business Overview Table 81. Shanxi Tiansheng Pharmaceutical Co., Ltd. Naoliqing Capsules Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 82. Shanxi Tiansheng Pharmaceutical Co., Ltd. Naoliqing Capsules Product Portfolio Table 83. Shanxi Tiansheng Pharmaceutical Co., Ltd. Recent Development Table 84. Shanxi Yellow River Chinese Medicine Co., Ltd. Company Information Table 85. Shanxi Yellow River Chinese Medicine Co., Ltd. Business Overview Table 86. Shanxi Yellow River Chinese Medicine Co., Ltd. Naoliqing Capsules Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 87. Shanxi Yellow River Chinese Medicine Co., Ltd. Naoliqing Capsules Product Portfolio Table 88. Shanxi Yellow River Chinese Medicine Co., Ltd. Recent Development Table 89. Shanxi Huayuan Pharmaceutical Biotechnology Co., Ltd. Company Information Table 90. Shanxi Huayuan Pharmaceutical Biotechnology Co., Ltd. Business Overview Table 91. Shanxi Huayuan Pharmaceutical Biotechnology Co., Ltd. Naoliqing Capsules Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 92. Shanxi Huayuan Pharmaceutical Biotechnology Co., Ltd. Naoliqing Capsules Product Portfolio Table 93. Shanxi Huayuan Pharmaceutical Biotechnology Co., Ltd. Recent Development Table 94. Shanxi Huakang Pharmaceutical Co., Ltd. Company Information Table 95. Shanxi Huakang Pharmaceutical Co., Ltd. Business Overview Table 96. Shanxi Huakang Pharmaceutical Co., Ltd. Naoliqing Capsules Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 97. Shanxi Huakang Pharmaceutical Co., Ltd. Naoliqing Capsules Product Portfolio Table 98. Shanxi Huakang Pharmaceutical Co., Ltd. Recent Development Table 99. Liaoyuan Yulong Yadong Pharmaceutical Co., Ltd. Company Information Table 100. Liaoyuan Yulong Yadong Pharmaceutical Co., Ltd. Business Overview Table 101. Liaoyuan Yulong Yadong Pharmaceutical Co., Ltd. Naoliqing Capsules Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 102. Liaoyuan Yulong Yadong Pharmaceutical Co., Ltd. Naoliqing Capsules Product Portfolio Table 103. Liaoyuan Yulong Yadong Pharmaceutical Co., Ltd. Recent Development Table 104. Jilin Zixin Pharmaceutical Co., Ltd. Company Information Table 105. Jilin Zixin Pharmaceutical Co., Ltd. Business Overview Table 106. Jilin Zixin Pharmaceutical Co., Ltd. Naoliqing Capsules Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 107. Jilin Zixin Pharmaceutical Co., Ltd. Naoliqing Capsules Product Portfolio Table 108. Jilin Zixin Pharmaceutical Co., Ltd. Recent Development Table 109. Jilin Yinok Pharmaceutical Co., Ltd. Company Information Table 110. Jilin Yinok Pharmaceutical Co., Ltd. Business Overview Table 111. Jilin Yinok Pharmaceutical Co., Ltd. Naoliqing Capsules Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 112. Jilin Yinok Pharmaceutical Co., Ltd. Naoliqing Capsules Product Portfolio Table 113. Jilin Yinok Pharmaceutical Co., Ltd. Recent Development Table 114. Jilin Tiantai Pharmaceutical Co., Ltd. Company Information Table 115. Jilin Tiantai Pharmaceutical Co., Ltd. Business Overview Table 116. Jilin Tiantai Pharmaceutical Co., Ltd. Naoliqing Capsules Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 117. Jilin Tiantai Pharmaceutical Co., Ltd. Naoliqing Capsules Product Portfolio Table 118. Jilin Tiantai Pharmaceutical Co., Ltd. Recent Development Table 119. Hubei Nordex Pharmaceutical Co., Ltd. Company Information Table 120. Hubei Nordex Pharmaceutical Co., Ltd. Business Overview Table 121. Hubei Nordex Pharmaceutical Co., Ltd. Naoliqing Capsules Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 122. Hubei Nordex Pharmaceutical Co., Ltd. Naoliqing Capsules Product Portfolio Table 123. Hubei Nordex Pharmaceutical Co., Ltd. Recent Development Table 124. Heilongjiang Dina Pharmaceutical Co., Ltd. Company Information Table 125. Heilongjiang Dina Pharmaceutical Co., Ltd. Business Overview Table 126. Heilongjiang Dina Pharmaceutical Co., Ltd. Naoliqing Capsules Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 127. Heilongjiang Dina Pharmaceutical Co., Ltd. Naoliqing Capsules Product Portfolio Table 128. Heilongjiang Dina Pharmaceutical Co., Ltd. Recent Development Table 129. Hebei Wansui Pharmaceutical Co., Ltd. Company Information Table 130. Hebei Wansui Pharmaceutical Co., Ltd. Business Overview Table 131. Hebei Wansui Pharmaceutical Co., Ltd. Naoliqing Capsules Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 132. Hebei Wansui Pharmaceutical Co., Ltd. Naoliqing Capsules Product Portfolio Table 133. Hebei Wansui Pharmaceutical Co., Ltd. Recent Development Table 134. Guizhou Hanfang Pharmaceutical Co., Ltd. Company Information Table 135. Guizhou Hanfang Pharmaceutical Co., Ltd. Business Overview Table 136. Guizhou Hanfang Pharmaceutical Co., Ltd. Naoliqing Capsules Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 137. Guizhou Hanfang Pharmaceutical Co., Ltd. Naoliqing Capsules Product Portfolio Table 138. Guizhou Hanfang Pharmaceutical Co., Ltd. Recent Development Table 139. Beijing Yadong Biopharmaceutical Co., Ltd. Company Information Table 140. Beijing Yadong Biopharmaceutical Co., Ltd. Business Overview Table 141. Beijing Yadong Biopharmaceutical Co., Ltd. Naoliqing Capsules Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 142. Beijing Yadong Biopharmaceutical Co., Ltd. Naoliqing Capsules Product Portfolio Table 143. Beijing Yadong Biopharmaceutical Co., Ltd. Recent Development Table 144. Beijing Boran Pharmaceutical Co., Ltd. Company Information Table 145. Beijing Boran Pharmaceutical Co., Ltd. Business Overview Table 146. Beijing Boran Pharmaceutical Co., Ltd. Naoliqing Capsules Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 147. Beijing Boran Pharmaceutical Co., Ltd. Naoliqing Capsules Product Portfolio Table 148. Beijing Boran Pharmaceutical Co., Ltd. Recent Development Table 149. Key Raw Materials Table 150. Raw Materials Key Suppliers Table 151. Naoliqing Capsules Distributors List Table 152. Naoliqing Capsules Customers List Table 153. Research Programs/Design for This Report Table 154. Authors List of This Report Table 155. Secondary Sources Table 156. Primary Sources List of Figures Figure 1. Naoliqing Capsules Product Image Figure 2. Global Naoliqing Capsules Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Naoliqing Capsules Sales Value (2021-2032) & (US$ Million) Figure 4. Global Naoliqing Capsules Sales (2021-2032) & (K Units) Figure 5. Global Naoliqing Capsules Sales Average Price (US$/Unit) & (2021-2032) Figure 6. Global Naoliqing Capsules Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Boxed Image Figure 10. Bottled Image Figure 11. Global Naoliqing Capsules Sales Volume by Type (2021 VS 2025 VS 2032) & (K Units) Figure 12. Global Naoliqing Capsules Sales Volume Share 2021 VS 2025 VS 2032 Figure 13. Global Naoliqing Capsules Sales Volume Share by Type (2021-2032) Figure 14. Global Naoliqing Capsules Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 15. Global Naoliqing Capsules Sales Value Share 2021 VS 2025 VS 2032 Figure 16. Global Naoliqing Capsules Sales Value Share by Type (2021-2032) Figure 17. Hospital Image Figure 18. Clinic Image Figure 19. Other Image Figure 20. Global Naoliqing Capsules Sales Volume by Application (2021 VS 2025 VS 2032) & (K Units) Figure 21. Global Naoliqing Capsules Sales Volume Share 2021 VS 2025 VS 2032 Figure 22. Global Naoliqing Capsules Sales Volume Share by Application (2021-2032) Figure 23. Global Naoliqing Capsules Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 24. Global Naoliqing Capsules Sales Value Share 2021 VS 2025 VS 2032 Figure 25. Global Naoliqing Capsules Sales Value Share by Application (2021-2032) Figure 26. Global Naoliqing Capsules Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 27. Global Naoliqing Capsules Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 28. Global Naoliqing Capsules Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 29. Global Naoliqing Capsules Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 30. North America Naoliqing Capsules Sales Value (2021-2032) & (US$ Million) Figure 31. North America Naoliqing Capsules Sales Value Share by Country (%), 2025 VS 2032 Figure 32. Europe Naoliqing Capsules Sales Value (2021-2032) & (US$ Million) Figure 33. Europe Naoliqing Capsules Sales Value Share by Country (%), 2025 VS 2032 Figure 34. Asia-Pacific Naoliqing Capsules Sales Value (2021-2032) & (US$ Million) Figure 35. Asia-Pacific Naoliqing Capsules Sales Value Share by Country (%), 2025 VS 2032 Figure 36. South America Naoliqing Capsules Sales Value (2021-2032) & (US$ Million) Figure 37. South America Naoliqing Capsules Sales Value Share by Country (%), 2025 VS 2032 Figure 38. Middle East & Africa Naoliqing Capsules Sales Value (2021-2032) & (US$ Million) Figure 39. Middle East & Africa Naoliqing Capsules Sales Value Share by Country (%), 2025 VS 2032 Figure 40. USA Naoliqing Capsules Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 41. USA Naoliqing Capsules Sales Value Share by Type, 2025 VS 2032 & (%) Figure 42. USA Naoliqing Capsules Sales Value Share by Application, 2025 VS 2032 & (%) Figure 43. Canada Naoliqing Capsules Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 44. Canada Naoliqing Capsules Sales Value Share by Type, 2025 VS 2032 & (%) Figure 45. Canada Naoliqing Capsules Sales Value Share by Application, 2025 VS 2032 & (%) Figure 46. Mexico Naoliqing Capsules Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 47. Mexico Naoliqing Capsules Sales Value Share by Type, 2025 VS 2032 & (%) Figure 48. Mexico Naoliqing Capsules Sales Value Share by Application, 2025 VS 2032 & (%) Figure 49. Germany Naoliqing Capsules Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 50. Germany Naoliqing Capsules Sales Value Share by Type, 2025 VS 2032 & (%) Figure 51. Germany Naoliqing Capsules Sales Value Share by Application, 2025 VS 2032 & (%) Figure 52. France Naoliqing Capsules Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 53. France Naoliqing Capsules Sales Value Share by Type, 2025 VS 2032 & (%) Figure 54. France Naoliqing Capsules Sales Value Share by Application, 2025 VS 2032 & (%) Figure 55. U.K. Naoliqing Capsules Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 56. U.K. Naoliqing Capsules Sales Value Share by Type, 2025 VS 2032 & (%) Figure 57. U.K. Naoliqing Capsules Sales Value Share by Application, 2025 VS 2032 & (%) Figure 58. Italy Naoliqing Capsules Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 59. Italy Naoliqing Capsules Sales Value Share by Type, 2025 VS 2032 & (%) Figure 60. Italy Naoliqing Capsules Sales Value Share by Application, 2025 VS 2032 & (%) Figure 61. Spain Naoliqing Capsules Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 62. Spain Naoliqing Capsules Sales Value Share by Type, 2025 VS 2032 & (%) Figure 63. Spain Naoliqing Capsules Sales Value Share by Application, 2025 VS 2032 & (%) Figure 64. Russia Naoliqing Capsules Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 65. Russia Naoliqing Capsules Sales Value Share by Type, 2025 VS 2032 & (%) Figure 66. Russia Naoliqing Capsules Sales Value Share by Application, 2025 VS 2032 & (%) Figure 67. Netherlands Naoliqing Capsules Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 68. Netherlands Naoliqing Capsules Sales Value Share by Type, 2025 VS 2032 & (%) Figure 69. Netherlands Naoliqing Capsules Sales Value Share by Application, 2025 VS 2032 & (%) Figure 70. Nordic Countries Naoliqing Capsules Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 71. Nordic Countries Naoliqing Capsules Sales Value Share by Type, 2025 VS 2032 & (%) Figure 72. Nordic Countries Naoliqing Capsules Sales Value Share by Application, 2025 VS 2032 & (%) Figure 73. China Naoliqing Capsules Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 74. China Naoliqing Capsules Sales Value Share by Type, 2025 VS 2032 & (%) Figure 75. China Naoliqing Capsules Sales Value Share by Application, 2025 VS 2032 & (%) Figure 76. Japan Naoliqing Capsules Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 77. Japan Naoliqing Capsules Sales Value Share by Type, 2025 VS 2032 & (%) Figure 78. Japan Naoliqing Capsules Sales Value Share by Application, 2025 VS 2032 & (%) Figure 79. South Korea Naoliqing Capsules Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 80. South Korea Naoliqing Capsules Sales Value Share by Type, 2025 VS 2032 & (%) Figure 81. South Korea Naoliqing Capsules Sales Value Share by Application, 2025 VS 2032 & (%) Figure 82. India Naoliqing Capsules Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 83. India Naoliqing Capsules Sales Value Share by Type, 2025 VS 2032 & (%) Figure 84. India Naoliqing Capsules Sales Value Share by Application, 2025 VS 2032 & (%) Figure 85. Australia Naoliqing Capsules Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 86. Australia Naoliqing Capsules Sales Value Share by Type, 2025 VS 2032 & (%) Figure 87. Australia Naoliqing Capsules Sales Value Share by Application, 2025 VS 2032 & (%) Figure 88. Southeast Asia Naoliqing Capsules Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 89. Southeast Asia Naoliqing Capsules Sales Value Share by Type, 2025 VS 2032 & (%) Figure 90. Southeast Asia Naoliqing Capsules Sales Value Share by Application, 2025 VS 2032 & (%) Figure 91. Brazil Naoliqing Capsules Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 92. Brazil Naoliqing Capsules Sales Value Share by Type, 2025 VS 2032 & (%) Figure 93. Brazil Naoliqing Capsules Sales Value Share by Application, 2025 VS 2032 & (%) Figure 94. Argentina Naoliqing Capsules Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 95. Argentina Naoliqing Capsules Sales Value Share by Type, 2025 VS 2032 & (%) Figure 96. Argentina Naoliqing Capsules Sales Value Share by Application, 2025 VS 2032 & (%) Figure 97. Chile Naoliqing Capsules Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 98. Chile Naoliqing Capsules Sales Value Share by Type, 2025 VS 2032 & (%) Figure 99. Chile Naoliqing Capsules Sales Value Share by Application, 2025 VS 2032 & (%) Figure 100. Colombia Naoliqing Capsules Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 101. Colombia Naoliqing Capsules Sales Value Share by Type, 2025 VS 2032 & (%) Figure 102. Colombia Naoliqing Capsules Sales Value Share by Application, 2025 VS 2032 & (%) Figure 103. Peru Naoliqing Capsules Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 104. Peru Naoliqing Capsules Sales Value Share by Type, 2025 VS 2032 & (%) Figure 105. Peru Naoliqing Capsules Sales Value Share by Application, 2025 VS 2032 & (%) Figure 106. Saudi Arabia Naoliqing Capsules Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 107. Saudi Arabia Naoliqing Capsules Sales Value Share by Type, 2025 VS 2032 & (%) Figure 108. Saudi Arabia Naoliqing Capsules Sales Value Share by Application, 2025 VS 2032 & (%) Figure 109. Israel Naoliqing Capsules Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 110. Israel Arabia Naoliqing Capsules Sales Value Share by Type, 2025 VS 2032 & (%) Figure 111. Israel Arabia Naoliqing Capsules Sales Value Share by Application, 2025 VS 2032 & (%) Figure 112. UAE Naoliqing Capsules Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 113. UAE Naoliqing Capsules Sales Value Share by Type, 2025 VS 2032 & (%) Figure 114. UAE Naoliqing Capsules Sales Value Share by Application, 2025 VS 2032 & (%) Figure 115. Turkey Naoliqing Capsules Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 116. Turkey Naoliqing Capsules Sales Value Share by Type, 2025 VS 2032 & (%) Figure 117. Turkey Naoliqing Capsules Sales Value Share by Application, 2025 VS 2032 & (%) Figure 118. Iran Naoliqing Capsules Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 119. Iran Naoliqing Capsules Sales Value Share by Type, 2025 VS 2032 & (%) Figure 120. Iran Naoliqing Capsules Sales Value Share by Application, 2025 VS 2032 & (%) Figure 121. Egypt Naoliqing Capsules Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 122. Egypt Naoliqing Capsules Sales Value Share by Type, 2025 VS 2032 & (%) Figure 123. Egypt Naoliqing Capsules Sales Value Share by Application, 2025 VS 2032 & (%) Figure 124. Naoliqing Capsules Value Chain Figure 125. Manufacturing Cost Structure Figure 126. Naoliqing Capsules Sales Mode & Process Figure 127. Direct Comparison with Distribution Share Figure 128. Distributors Profiles Figure 129. Years Considered Figure 130. Research Process Figure 131. Key Executives Interviewed

Scope & coverage.

Types
  • Boxed
  • Bottled
Applications
  • Hospital
  • Clinic
  • Other
Companies covered
  • Xiuzhen Pharmaceutical Group Co., Ltd.
  • Xi'an Tianyi Qinkun Pharmaceutical Co., Ltd.
  • Tonghua Xindongri Pharmaceutical Co., Ltd.
  • Shanxi Tiansheng Pharmaceutical Co., Ltd.
  • Shanxi Yellow River Chinese Medicine Co., Ltd.
  • Shanxi Huayuan Pharmaceutical Biotechnology Co., Ltd.
  • Shanxi Huakang Pharmaceutical Co., Ltd.
  • Liaoyuan Yulong Yadong Pharmaceutical Co., Ltd.
  • Jilin Zixin Pharmaceutical Co., Ltd.
  • Jilin Yinok Pharmaceutical Co., Ltd.
  • Jilin Tiantai Pharmaceutical Co., Ltd.
  • Hubei Nordex Pharmaceutical Co., Ltd.
  • Heilongjiang Dina Pharmaceutical Co., Ltd.
  • Hebei Wansui Pharmaceutical Co., Ltd.
  • Guizhou Hanfang Pharmaceutical Co., Ltd.
  • Beijing Yadong Biopharmaceutical Co., Ltd.
  • Beijing Boran Pharmaceutical Co., Ltd.

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Naoliqing Capsules Sales Value (2021-2032)
  4. 1.2.2 Global Naoliqing Capsules Sales Volume (2021-2032)
  5. 1.2.3 Global Naoliqing Capsules Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Naoliqing Capsules Market Dynamics
  1. 2.1 Naoliqing Capsules Industry Trends
  2. 2.2 Naoliqing Capsules Industry Drivers
  3. 2.3 Naoliqing Capsules Industry Opportunities and Challenges
  4. 2.4 Naoliqing Capsules Industry Restraints
3 Naoliqing Capsules Market by Company
  1. 3.1 Global Naoliqing Capsules Company Revenue Ranking in 2025
  2. 3.2 Global Naoliqing Capsules Revenue by Company (2021-2026)
  3. 3.3 Global Naoliqing Capsules Sales Volume by Company (2021-2026)
  4. 3.4 Global Naoliqing Capsules Average Price by Company (2021-2026)
  5. 3.5 Global Naoliqing Capsules Company Ranking (2024-2026)
  6. 3.6 Global Naoliqing Capsules Company Manufacturing Base and Headquarters
  7. 3.7 Global Naoliqing Capsules Company Product Type and Application
  8. 3.8 Global Naoliqing Capsules Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Naoliqing Capsules Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Naoliqing Capsules Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Naoliqing Capsules Market by Type
  1. 4.1 Naoliqing Capsules Type Introduction
  2. 4.1.1 Boxed
  3. 4.1.2 Bottled
  4. 4.2 Global Naoliqing Capsules Sales Volume by Type
  5. 4.2.1 Global Naoliqing Capsules Sales Volume by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Naoliqing Capsules Sales Volume by Type (2021-2032)
  7. 4.2.3 Global Naoliqing Capsules Sales Volume Share by Type (2021-2032)
  8. 4.3 Global Naoliqing Capsules Sales Value by Type
  9. 4.3.1 Global Naoliqing Capsules Sales Value by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Naoliqing Capsules Sales Value by Type (2021-2032)
  11. 4.3.3 Global Naoliqing Capsules Sales Value Share by Type (2021-2032)
5 Naoliqing Capsules Market by Application
  1. 5.1 Naoliqing Capsules Application Introduction
  2. 5.1.1 Hospital
  3. 5.1.2 Clinic
  4. 5.1.3 Other
  5. 5.2 Global Naoliqing Capsules Sales Volume by Application
  6. 5.2.1 Global Naoliqing Capsules Sales Volume by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Naoliqing Capsules Sales Volume by Application (2021-2032)
  8. 5.2.3 Global Naoliqing Capsules Sales Volume Share by Application (2021-2032)
  9. 5.3 Global Naoliqing Capsules Sales Value by Application
  10. 5.3.1 Global Naoliqing Capsules Sales Value by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Naoliqing Capsules Sales Value by Application (2021-2032)
  12. 5.3.3 Global Naoliqing Capsules Sales Value Share by Application (2021-2032)
6 Naoliqing Capsules Regional Sales and Value Analysis
  1. 6.1 Global Naoliqing Capsules Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Naoliqing Capsules Sales by Region (2021-2032)
  3. 6.2.1 Global Naoliqing Capsules Sales by Region: 2021-2026
  4. 6.2.2 Global Naoliqing Capsules Sales by Region (2027-2032)
  5. 6.3 Global Naoliqing Capsules Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Naoliqing Capsules Sales Value by Region (2021-2032)
  7. 6.4.1 Global Naoliqing Capsules Sales Value by Region: 2021-2026
  8. 6.4.2 Global Naoliqing Capsules Sales Value by Region (2027-2032)
  9. 6.5 Global Naoliqing Capsules Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Naoliqing Capsules Sales Value (2021-2032)
  12. 6.6.2 North America Naoliqing Capsules Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Naoliqing Capsules Sales Value (2021-2032)
  15. 6.7.2 Europe Naoliqing Capsules Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Naoliqing Capsules Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Naoliqing Capsules Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Naoliqing Capsules Sales Value (2021-2032)
  21. 6.9.2 South America Naoliqing Capsules Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Naoliqing Capsules Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Naoliqing Capsules Sales Value Share by Country, 2025 VS 2032
7 Naoliqing Capsules Country-level Sales and Value Analysis
  1. 7.1 Global Naoliqing Capsules Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Naoliqing Capsules Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Naoliqing Capsules Sales by Country (2021-2032)
  4. 7.3.1 Global Naoliqing Capsules Sales by Country (2021-2026)
  5. 7.3.2 Global Naoliqing Capsules Sales by Country (2027-2032)
  6. 7.4 Global Naoliqing Capsules Sales Value by Country (2021-2032)
  7. 7.4.1 Global Naoliqing Capsules Sales Value by Country (2021-2026)
  8. 7.4.2 Global Naoliqing Capsules Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Naoliqing Capsules Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Naoliqing Capsules Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Naoliqing Capsules Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Naoliqing Capsules Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Naoliqing Capsules Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Naoliqing Capsules Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Naoliqing Capsules Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Naoliqing Capsules Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Naoliqing Capsules Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Naoliqing Capsules Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Naoliqing Capsules Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Naoliqing Capsules Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Naoliqing Capsules Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Naoliqing Capsules Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Naoliqing Capsules Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Naoliqing Capsules Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Naoliqing Capsules Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Naoliqing Capsules Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Naoliqing Capsules Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Naoliqing Capsules Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Naoliqing Capsules Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Naoliqing Capsules Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Naoliqing Capsules Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Naoliqing Capsules Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Naoliqing Capsules Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Naoliqing Capsules Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Naoliqing Capsules Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Naoliqing Capsules Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Naoliqing Capsules Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Naoliqing Capsules Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Naoliqing Capsules Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Naoliqing Capsules Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Naoliqing Capsules Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Naoliqing Capsules Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Naoliqing Capsules Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Naoliqing Capsules Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Naoliqing Capsules Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Naoliqing Capsules Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Naoliqing Capsules Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Naoliqing Capsules Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Naoliqing Capsules Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Naoliqing Capsules Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Naoliqing Capsules Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Naoliqing Capsules Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Naoliqing Capsules Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Naoliqing Capsules Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Naoliqing Capsules Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Naoliqing Capsules Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Naoliqing Capsules Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Naoliqing Capsules Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Naoliqing Capsules Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Naoliqing Capsules Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Naoliqing Capsules Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Naoliqing Capsules Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Naoliqing Capsules Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Naoliqing Capsules Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Naoliqing Capsules Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Naoliqing Capsules Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Naoliqing Capsules Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Naoliqing Capsules Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Naoliqing Capsules Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Naoliqing Capsules Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Naoliqing Capsules Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Naoliqing Capsules Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Naoliqing Capsules Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Naoliqing Capsules Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Naoliqing Capsules Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Naoliqing Capsules Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Naoliqing Capsules Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Naoliqing Capsules Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Naoliqing Capsules Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Naoliqing Capsules Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Naoliqing Capsules Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Naoliqing Capsules Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Naoliqing Capsules Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Naoliqing Capsules Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Naoliqing Capsules Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Naoliqing Capsules Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Naoliqing Capsules Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Naoliqing Capsules Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Naoliqing Capsules Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Naoliqing Capsules Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Naoliqing Capsules Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Naoliqing Capsules Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Xiuzhen Pharmaceutical Group Co., Ltd.
  2. 8.1.1 Xiuzhen Pharmaceutical Group Co., Ltd. Company Information
  3. 8.1.2 Xiuzhen Pharmaceutical Group Co., Ltd. Business Overview
  4. 8.1.3 Xiuzhen Pharmaceutical Group Co., Ltd. Naoliqing Capsules Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Xiuzhen Pharmaceutical Group Co., Ltd. Naoliqing Capsules Product Portfolio
  6. 8.1.5 Xiuzhen Pharmaceutical Group Co., Ltd. Recent Developments
  7. 8.2 Xi'an Tianyi Qinkun Pharmaceutical Co., Ltd.
  8. 8.2.1 Xi'an Tianyi Qinkun Pharmaceutical Co., Ltd. Company Information
  9. 8.2.2 Xi'an Tianyi Qinkun Pharmaceutical Co., Ltd. Business Overview
  10. 8.2.3 Xi'an Tianyi Qinkun Pharmaceutical Co., Ltd. Naoliqing Capsules Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Xi'an Tianyi Qinkun Pharmaceutical Co., Ltd. Naoliqing Capsules Product Portfolio
  12. 8.2.5 Xi'an Tianyi Qinkun Pharmaceutical Co., Ltd. Recent Developments
  13. 8.3 Tonghua Xindongri Pharmaceutical Co., Ltd.
  14. 8.3.1 Tonghua Xindongri Pharmaceutical Co., Ltd. Company Information
  15. 8.3.2 Tonghua Xindongri Pharmaceutical Co., Ltd. Business Overview
  16. 8.3.3 Tonghua Xindongri Pharmaceutical Co., Ltd. Naoliqing Capsules Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Tonghua Xindongri Pharmaceutical Co., Ltd. Naoliqing Capsules Product Portfolio
  18. 8.3.5 Tonghua Xindongri Pharmaceutical Co., Ltd. Recent Developments
  19. 8.4 Shanxi Tiansheng Pharmaceutical Co., Ltd.
  20. 8.4.1 Shanxi Tiansheng Pharmaceutical Co., Ltd. Company Information
  21. 8.4.2 Shanxi Tiansheng Pharmaceutical Co., Ltd. Business Overview
  22. 8.4.3 Shanxi Tiansheng Pharmaceutical Co., Ltd. Naoliqing Capsules Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Shanxi Tiansheng Pharmaceutical Co., Ltd. Naoliqing Capsules Product Portfolio
  24. 8.4.5 Shanxi Tiansheng Pharmaceutical Co., Ltd. Recent Developments
  25. 8.5 Shanxi Yellow River Chinese Medicine Co., Ltd.
  26. 8.5.1 Shanxi Yellow River Chinese Medicine Co., Ltd. Company Information
  27. 8.5.2 Shanxi Yellow River Chinese Medicine Co., Ltd. Business Overview
  28. 8.5.3 Shanxi Yellow River Chinese Medicine Co., Ltd. Naoliqing Capsules Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Shanxi Yellow River Chinese Medicine Co., Ltd. Naoliqing Capsules Product Portfolio
  30. 8.5.5 Shanxi Yellow River Chinese Medicine Co., Ltd. Recent Developments
  31. 8.6 Shanxi Huayuan Pharmaceutical Biotechnology Co., Ltd.
  32. 8.6.1 Shanxi Huayuan Pharmaceutical Biotechnology Co., Ltd. Company Information
  33. 8.6.2 Shanxi Huayuan Pharmaceutical Biotechnology Co., Ltd. Business Overview
  34. 8.6.3 Shanxi Huayuan Pharmaceutical Biotechnology Co., Ltd. Naoliqing Capsules Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Shanxi Huayuan Pharmaceutical Biotechnology Co., Ltd. Naoliqing Capsules Product Portfolio
  36. 8.6.5 Shanxi Huayuan Pharmaceutical Biotechnology Co., Ltd. Recent Developments
  37. 8.7 Shanxi Huakang Pharmaceutical Co., Ltd.
  38. 8.7.1 Shanxi Huakang Pharmaceutical Co., Ltd. Company Information
  39. 8.7.2 Shanxi Huakang Pharmaceutical Co., Ltd. Business Overview
  40. 8.7.3 Shanxi Huakang Pharmaceutical Co., Ltd. Naoliqing Capsules Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 Shanxi Huakang Pharmaceutical Co., Ltd. Naoliqing Capsules Product Portfolio
  42. 8.7.5 Shanxi Huakang Pharmaceutical Co., Ltd. Recent Developments
  43. 8.8 Liaoyuan Yulong Yadong Pharmaceutical Co., Ltd.
  44. 8.8.1 Liaoyuan Yulong Yadong Pharmaceutical Co., Ltd. Company Information
  45. 8.8.2 Liaoyuan Yulong Yadong Pharmaceutical Co., Ltd. Business Overview
  46. 8.8.3 Liaoyuan Yulong Yadong Pharmaceutical Co., Ltd. Naoliqing Capsules Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 Liaoyuan Yulong Yadong Pharmaceutical Co., Ltd. Naoliqing Capsules Product Portfolio
  48. 8.8.5 Liaoyuan Yulong Yadong Pharmaceutical Co., Ltd. Recent Developments
  49. 8.9 Jilin Zixin Pharmaceutical Co., Ltd.
  50. 8.9.1 Jilin Zixin Pharmaceutical Co., Ltd. Company Information
  51. 8.9.2 Jilin Zixin Pharmaceutical Co., Ltd. Business Overview
  52. 8.9.3 Jilin Zixin Pharmaceutical Co., Ltd. Naoliqing Capsules Sales, Value and Gross Margin (2021-2026)
  53. 8.9.4 Jilin Zixin Pharmaceutical Co., Ltd. Naoliqing Capsules Product Portfolio
  54. 8.9.5 Jilin Zixin Pharmaceutical Co., Ltd. Recent Developments
  55. 8.10 Jilin Yinok Pharmaceutical Co., Ltd.
  56. 8.10.1 Jilin Yinok Pharmaceutical Co., Ltd. Company Information
  57. 8.10.2 Jilin Yinok Pharmaceutical Co., Ltd. Business Overview
  58. 8.10.3 Jilin Yinok Pharmaceutical Co., Ltd. Naoliqing Capsules Sales, Value and Gross Margin (2021-2026)
  59. 8.10.4 Jilin Yinok Pharmaceutical Co., Ltd. Naoliqing Capsules Product Portfolio
  60. 8.10.5 Jilin Yinok Pharmaceutical Co., Ltd. Recent Developments
  61. 8.11 Jilin Tiantai Pharmaceutical Co., Ltd.
  62. 8.11.1 Jilin Tiantai Pharmaceutical Co., Ltd. Company Information
  63. 8.11.2 Jilin Tiantai Pharmaceutical Co., Ltd. Business Overview
  64. 8.11.3 Jilin Tiantai Pharmaceutical Co., Ltd. Naoliqing Capsules Sales, Value and Gross Margin (2021-2026)
  65. 8.11.4 Jilin Tiantai Pharmaceutical Co., Ltd. Naoliqing Capsules Product Portfolio
  66. 8.11.5 Jilin Tiantai Pharmaceutical Co., Ltd. Recent Developments
  67. 8.12 Hubei Nordex Pharmaceutical Co., Ltd.
  68. 8.12.1 Hubei Nordex Pharmaceutical Co., Ltd. Company Information
  69. 8.12.2 Hubei Nordex Pharmaceutical Co., Ltd. Business Overview
  70. 8.12.3 Hubei Nordex Pharmaceutical Co., Ltd. Naoliqing Capsules Sales, Value and Gross Margin (2021-2026)
  71. 8.12.4 Hubei Nordex Pharmaceutical Co., Ltd. Naoliqing Capsules Product Portfolio
  72. 8.12.5 Hubei Nordex Pharmaceutical Co., Ltd. Recent Developments
  73. 8.13 Heilongjiang Dina Pharmaceutical Co., Ltd.
  74. 8.13.1 Heilongjiang Dina Pharmaceutical Co., Ltd. Company Information
  75. 8.13.2 Heilongjiang Dina Pharmaceutical Co., Ltd. Business Overview
  76. 8.13.3 Heilongjiang Dina Pharmaceutical Co., Ltd. Naoliqing Capsules Sales, Value and Gross Margin (2021-2026)
  77. 8.13.4 Heilongjiang Dina Pharmaceutical Co., Ltd. Naoliqing Capsules Product Portfolio
  78. 8.13.5 Heilongjiang Dina Pharmaceutical Co., Ltd. Recent Developments
  79. 8.14 Hebei Wansui Pharmaceutical Co., Ltd.
  80. 8.14.1 Hebei Wansui Pharmaceutical Co., Ltd. Company Information
  81. 8.14.2 Hebei Wansui Pharmaceutical Co., Ltd. Business Overview
  82. 8.14.3 Hebei Wansui Pharmaceutical Co., Ltd. Naoliqing Capsules Sales, Value and Gross Margin (2021-2026)
  83. 8.14.4 Hebei Wansui Pharmaceutical Co., Ltd. Naoliqing Capsules Product Portfolio
  84. 8.14.5 Hebei Wansui Pharmaceutical Co., Ltd. Recent Developments
  85. 8.15 Guizhou Hanfang Pharmaceutical Co., Ltd.
  86. 8.15.1 Guizhou Hanfang Pharmaceutical Co., Ltd. Company Information
  87. 8.15.2 Guizhou Hanfang Pharmaceutical Co., Ltd. Business Overview
  88. 8.15.3 Guizhou Hanfang Pharmaceutical Co., Ltd. Naoliqing Capsules Sales, Value and Gross Margin (2021-2026)
  89. 8.15.4 Guizhou Hanfang Pharmaceutical Co., Ltd. Naoliqing Capsules Product Portfolio
  90. 8.15.5 Guizhou Hanfang Pharmaceutical Co., Ltd. Recent Developments
  91. 8.16 Beijing Yadong Biopharmaceutical Co., Ltd.
  92. 8.16.1 Beijing Yadong Biopharmaceutical Co., Ltd. Company Information
  93. 8.16.2 Beijing Yadong Biopharmaceutical Co., Ltd. Business Overview
  94. 8.16.3 Beijing Yadong Biopharmaceutical Co., Ltd. Naoliqing Capsules Sales, Value and Gross Margin (2021-2026)
  95. 8.16.4 Beijing Yadong Biopharmaceutical Co., Ltd. Naoliqing Capsules Product Portfolio
  96. 8.16.5 Beijing Yadong Biopharmaceutical Co., Ltd. Recent Developments
  97. 8.17 Beijing Boran Pharmaceutical Co., Ltd.
  98. 8.17.1 Beijing Boran Pharmaceutical Co., Ltd. Company Information
  99. 8.17.2 Beijing Boran Pharmaceutical Co., Ltd. Business Overview
  100. 8.17.3 Beijing Boran Pharmaceutical Co., Ltd. Naoliqing Capsules Sales, Value and Gross Margin (2021-2026)
  101. 8.17.4 Beijing Boran Pharmaceutical Co., Ltd. Naoliqing Capsules Product Portfolio
  102. 8.17.5 Beijing Boran Pharmaceutical Co., Ltd. Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Naoliqing Capsules Value Chain Analysis
  2. 9.1.1 Naoliqing Capsules Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Naoliqing Capsules Sales Mode & Process
  6. 9.2 Naoliqing Capsules Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Naoliqing Capsules Distributors
  9. 9.2.3 Naoliqing Capsules Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst